-
Vonn to provide injury update as Milan-Cortina Olympics near
-
France summons Musk for 'voluntary interview', raids X offices
-
Stocks mostly climb as gold recovers
-
US judge to hear request for 'immediate takedown' of Epstein files
-
Russia resumes large-scale strikes on Ukraine in glacial temperatures
-
Fit-again France captain Dupont partners Jalibert against Ireland
-
French summons Musk for 'voluntary interview' as authorities raid X offices
-
IOC chief Coventry calls for focus on sport, not politics
-
McNeil's partner hits out at 'brutal' football industry after Palace move collapses
-
Proud moment as Prendergast brothers picked to start for Ireland
-
Germany has highest share of older workers in EU
-
Teen swims four hours to save family lost at sea off Australia
-
Ethiopia denies Trump claim mega-dam was financed by US
-
Norway crown princess's son pleads not guilty to rapes as trial opens
-
Russia resumes strikes on freezing Ukrainian capital ahead of talks
-
Malaysian court acquits French man on drug charges
-
Switch 2 sales boost Nintendo profits, but chip shortage looms
-
China to ban hidden car door handles, setting new safety standards
-
Switch 2 sales boost Nintendo results but chip shortage looms
-
From rations to G20's doorstep: Poland savours economic 'miracle'
-
Russia resumes strikes on freezing Ukrainian capital
-
'Way too far': Latino Trump voters shocked by Minneapolis crackdown
-
England and Brook seek redemption at T20 World Cup
-
Coach Gambhir under pressure as India aim for back-to-back T20 triumphs
-
'Helmets off': NFL stars open up as Super Bowl circus begins
-
Japan coach Jones says 'fair' World Cup schedule helps small teams
-
Equities and precious metals rebound after Asia-wide rout
-
Do not write Ireland off as a rugby force, says ex-prop Ross
-
Winter Olympics 2026: AFP guide to Alpine Skiing races
-
Winter Olympics to showcase Italian venues and global tensions
-
Buoyant England eager to end Franco-Irish grip on Six Nations
-
China to ban hidden car door handles in industry shift
-
Sengun leads Rockets past Pacers, Ball leads Hornets fightback
-
Waymo raises $16 bn to fuel global robotaxi expansion
-
Netflix to livestream BTS comeback concert in K-pop mega event
-
Rural India powers global AI models
-
US House to vote Tuesday to end shutdown
-
Equities, metals, oil rebound after Asia-wide rout
-
Bencic, Svitolina make history as mothers inside tennis top 10
-
Italy's spread-out Olympics face transport challenge
-
Son of Norway crown princess stands trial for multiple rapes
-
Side hustle: Part-time refs take charge of Super Bowl
-
Paying for a selfie: Rome starts charging for Trevi Fountain
-
Faced with Trump, Pope Leo opts for indirect diplomacy
-
NFL chief expects Bad Bunny to unite Super Bowl audience
-
Australia's Hazlewood to miss start of T20 World Cup
-
Bill, Hillary Clinton to testify in US House Epstein probe
-
Cuba confirms 'communications' with US, but says no negotiations yet
-
Iran orders talks with US as Trump warns of 'bad things' if no deal reached
-
Spiffy and Blink AI Automotive Announce Strategic Partnership to Advance Mobile Service for Automotive Dealers
Featured
Last news
Havertys Furniture Reports Operating Results for Third Quarter 2025
ATLANTA, GA / ACCESS Newswire / October 29, 2025 / Haverty Furniture Companies, Inc. (NYSE:HVT)(NYSE:HVT.A), today reported operating results for the third quarter ended September 30, 2025.
Bausch Health Announces Third Quarter 2025 Results
Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over the prior year periodGAAP Net Income Attributable to Bausch Health of $179 million and GAAP Net Income of $181 millionConsolidated Adjusted EBITDA Attributable to Bausch Health (non-GAAP)1 of $986 million, including an $81 million acquired In-Process Research & Development ("IPR&D") charge, up 8% on a Reported basis over the prior year periodBAUSCH HEALTH EXCLUDING BAUSCH + LOMB THIRD QUARTER 2025 RESULTSDelivered tenth consecutive quarter of year-over-year Revenue and Adjusted EBITDA (non-GAAP)1 growth, with 7% Reported and 5% Organic (non-GAAP)1 Revenue growth, and 7% Adjusted EBITDA (non-GAAP)1 growth, including an $81 million charge for acquired IPR&DRaising full-year 2025 Revenue, Adjusted EBITDA (non-GAAP)1, and Adjusted Cash Flow from Operations (non-GAAP)1 guidanceCompleted acquisition of DURECT Corporation, expanding Bausch Health's hepatology portfolio with addition of lead asset, Larsucosterol, a novel epigenetic modulator with FDA Breakthrough Therapy Designation for treatment of alcohol-associated hepatitis ("AH")
Institutional Capital Confirms Marijuana Future: MMJ International Holdings FDA Regulated Plant Based Medicine
As President Trump reforms government inefficiency Wall Street backs pharmaceutical grade plant therapeutics, MMJ International Holdings-under President & CEO Duane Boise-proves that the future of cannabis in medicine lies not in dispensaries, but in data-driven science and FDA regulation.
Insurgence Original IT NEEDS EYES Playing Halloween Eve At The AMT Theater Manhattan
Horror Thriller Shows What Can Happen When The Internet Goes Very Wrong
The Battery Show North America Celebrates 15th Anniversary Connecting Global Battery and EV Tech Community
DETROIT, MI / ACCESS Newswire / October 29, 2025 / The Battery Show and Electric & Hybrid Vehicle Technology Expo cemented its status as the leading advanced battery and EV event in North America, concluding October 9th after four days dedicated to the cutting-edge products and innovations revolutionizing battery technology. (October 6-9, Huntington Place, Detroit)
FLEX(C) to Host Exclusive Master Classes, Live Demonstrations and Daily Giveaways at the 2025 SEMA Show
LAS VEGAS, NV / ACCESS Newswire / October 29, 2025 / Visitors of FLEX's booth #51125 in the West Hall at the 2025 SEMA Show will experience live hands-on training, expert-led demonstrations and exclusive giveaways designed to celebrate innovation and craftsmanship in the detailing industry.
Michael Jordan Game-Worn Memorabilia Headlines Infinite Auctions (Subsidiary of MDCE) Fall Flash Auction
MESA, ARIZONA / ACCESS Newswire / October 29, 2025 / Infinite Auctions, a subsidiary of Medical Care Technologies Inc. (OTC Pink:MDCE), is proud to announce the launch of its Fall Flash Auction, opening this Saturday at www.infiniteauctions.com. This special event features a smaller but elite lineup of game-worn memorabilia and autographed collectibles from some of the greatest athletes in sports history.
Interactive Strength Inc. (NASDAQ:TRNR) Appoints Caleb Morgret as CFO To Drive the Transformation to Beyond $80m In Expected 2025 Pro Forma Revenue
Mr. Morgret, a German speaker, has been working with TRNR since September, with a sole focus on the audit and financial workflows required to complete the acquisition of SportstechMr. Morgret is based in Europe, the region that will generate substantially all of TRNR's expected 2025 pro forma revenue of more than $80M, and will transition to CFO on November 15Michael Madigan, TRNR's current CFO, to step down after Q3 earnings on November 14, having taken the company public and guided it through two significant acquisitions
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
SAN DIEGO, CA / ACCESS Newswire / October 29, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the October 15, 2025 Special Meeting of Stockholders of Revelation Biosciences, Inc. (the "Company"), which was adjourned to October 29, 2025 has been canceled due to technical difficulty outside of the Company's control with stockholders being unable to vote all of their shares. The Company has decided to cancel the adjourned Special Meeting scheduled for today, October 29, at 12pm ET and to set a new record date of October 29, 2025 for a new Special Meeting of Stockholders to take place on December 3, 2025. The Company will issue new proxy materials to all stockholders of record as of the new record date in connection with this meeting. The Company encourages all stockholders to vote their shares promptly upon receipt of the proxy materials.
La Mer Beachfront Resort Unveils Its Newest Creation - a Dazzling "Sapphire Christmas" on the Jersey Shore as a New Holiday Landmark Arrives in Cape May
Standing at an impressive 30 feet and crowned with a three-foot illuminated star, the show-stopping tree is designed to dazzle and delight. Each branch will shimmer with 210 radiant sapphire lights, culminating in a breathtaking total of 32,340 lights that will bathe the resort in a mesmerizing sapphire glow throughout the holiday season.
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share major progress in the company's antiviral research in a video interview. The interview can be viewed at https://youtu.be/m_3Yk4_832E .
New Release Shines Light on a Shocking True Story of Justice Denied
USA v Raj by Dr. Raj Bothra and Jenifer DeBellis Released September 11, 2025
New Generation Consumer Group's Signature Apps in Talks to Acquire Revenue-Generating Subscription App Companies
PHOENIX, AZ / ACCESS Newswire / October 29, 2025 / New Generation Consumer Group (OTCID:NGCG) announced today that its subsidiary, Signature Apps, is in active discussions to acquire multiple revenue-generating app and service companies. The target companies operate on subscription-based models, delivering consistent, recurring revenues that align with Signature Apps' strategy to scale its digital product suite and expand its customer base.
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime
Specificity Signs LOI with Blackpearl Group to Build the World's Only Fully Integrated Ad Tech Stack, Launching a Direct Attack on Big Tech Fraud
TAMPA, FLORIDA / ACCESS Newswire / October 29, 2025 / Specificity (OTCID:SPTY), the leader in precision digital marketing, today announced it has signed a Letter of Intent (LOI) with New Zealand-based Blackpearl Group (BPG) to build and host a proprietary Private Data Platform- creating what companies describe as the world's only fully integrated ad tech stack. This move cements Specificity's path to major market disruption and positions the company to tackle the estimated $250 billion fraud problem plaguing the digital advertising industry, driven largely by bot and mechanical traffic.
Lex LasVegas to Emcee Compassion Center's Coalition for Patient Rights Inaugural Hoedown, Nov. 15 at Paradise Recreation Center
The Compassion Center and its Coalition for Patient Rights (CPR) tap Las Vegas mainstay Lex LasVegas to host a family-friendly day of music, advocacy, and community well-being on Saturday, November 15, 2025, 10 a.m.-6 p.m., at 4775 McLeod Dr., Las Vegas, NV 89121. In the lead-up, fans are invited to The Official 4Horsemen of Comedy Costume Party & Legendary 4Horseman Khalil Mack's Birthday on Wednesday, October 29, 2025, 9 p.m.-1 a.m.++ at Hola Habibi, with Blaque Tacos and a prize for Best Outfit.
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025.
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
DSMB Clearance to Proceed to the Next Dose Level of HG-CT-1 in Adult Patients, Opening Pediatric Recruitment, and Grant of Restricted Share Units to Hemogenyx Team
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
RLF-OD032 demonstrated bioequivalence to KUVAN® PowderStudy results support planned 505(b)(2) NDA submission in early 2026
'Catastrophic' hurricane slams Jamaica with fierce winds and rain
Hurricane Melissa ripped up trees and knocked out power after making landfall in Jamaica on Tuesday as one of the most powerful hurricanes on record, inundating the island nation with rains that threaten flash floods and landslides.
At least 64 killed in war-like Rio drug raids
Bodies piled up in poor neighborhoods of Rio de Janeiro on Tuesday as police launched their biggest ever raids on the city's drug traffickers, leaving at least 64 dead in war-like scenes.
At least 64 killed in Rio drug raid
Hundreds of heavily armed Brazilian police raided slum areas of Rio in a drug raid Tuesday, touching off firefights likened to scenes from a war and leaving at least 64 people dead, Brazilian officials said.
French prosecutors seek suspended jail terms in Brigitte Macron cyberbullying case
French prosecutors on Tuesday sought suspended prison terms of three to 12 months for defendants accused of cyberbullying First Lady Brigitte Macron by spreading unsubstantiated claims about her gender.
At least 18 suspects killed in Rio anti-drug raid: governor
At least 18 suspects and some police officers were killed Tuesday during a massive anti-drug raid in Rio de Janeiro, Brazilian authorities said, as prolonged gun battles erupted and demolition vehicles destroyed street barricades.
Giant Hurricane Melissa hours from bullseye hit on Jamaica
Hurricane Melissa was only hours away Tuesday from expected landfall on Jamaica, bringing devastating flooding and winds that officials warn will smash the small Caribbean nation's infrastructure.
The Voice of the Martyrs Releases Daniel and Aline: Democratic Republic of the Congo, a Short Film for 2025 International Day of Prayer for Persecuted Christians
BARTLESVILLE, OK / ACCESS Newswire / October 28, 2025 / The Voice of the Martyrs (VOM) has released a new short feature film telling the powerful story of Daniel and Aline, two courageous Congolese Christians bringing hope and healing to fellow believers traumatized by kidnapping, violence and loss in the Democratic Republic of the Congo (DRC).
Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series
DOHC strengthens its commitment to mothers and families through expanded education and personalized prenatal support
Newsmax to Report Third Quarter 2025 Financial Results
BOCA RATON, FL / ACCESS Newswire / October 28, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that the Company will report financial results for the third quarter ended September 30, 2025 on Thursday, November 13, 2025, after the U.S. stock market closes.
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma (NASDAQ:SBFM) is quickly establishing which side of that line it's on. After scoring another major regulatory win, that position certainly isn't one of many in the crowd. On Tuesday, the company announced that it had secured Health Canada authorization to commercialize domperidone through its Nora Pharma subsidiary, a milestone that not only expands its commercial reach but also validates its growing track record of revenue-generating execution.
Who is Javad Sajan?
Javad Sajan is the best plastic surgeon in Seattle.
Vanderbilt Report NextTrip CEO Interview: NextTrip Builds What Traditional Travel Companies Couldn't
BRISTOL, TN / ACCESS Newswire / October 28, 2025 / Most online travel agencies can't prove their advertising works.
Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA
Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage.